Latest news
Loading news…
Aquilon CyL
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. León, Castilla y Leon, Spain Founded 2012 1-10 employees For Profit
Aquilon CyL is a Spherium Biomed spin-out that develops intellectual property for the veterinary field.
Aquilon CyL was acquired by Ceva Santé Animale in 2026.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
14
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 14
- Trademarks
- 2
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $325K
Company Info
- Founded
- 2012
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 2
- HQ
- León, Castilla y Leon, Spain
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jun 9, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- -2.2
- Trend (90d)
- 5.7
Key People at Aquilon CyL
CEO
1
professional contacts at Aquilon CyL
Contact execs at Aquilon CyL →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aquilon CyL
Loading news…
FAQs about Aquilon CyL
People who checked this page also checked these
Browse the full Acquirezy directory.